Home »
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. COVID vaccines do not work well for patients with hematologic malignancies, new data suggest. A small study involving 67 such patients
(Reuters) – Australia and the Philippines limited use of AstraZeneca’s COVID-19 vaccine on Thursday, while the Africa Union dropped plans to buy the shot, dealing further blows to the company’s hopes to deliver a vaccine
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. In its review of possible adverse effects with the AstraZeneca COVID-19 vaccine, the European Medicines Agency (EMA) has again concluded that
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. This week, Florida expanded eligibility for COVID-19 vaccines to all residents aged 16 years and older. But across the state, more
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. With a mix of relief and caution, older adults fully vaccinated against covid-19 are moving out into the world and resuming
These are the global coronavirus stories you need to know about this week. Brazil is facing a worsening COVID-19 situation with 18 states having ICU occupancy rates above 90% on Tuesday, and 100% in Amapá and
LONDON/CHICAGO (Reuters) – Scientists who have watched with dismay a series of disputes over AstraZeneca’s COVID-19 vaccine say strong efficacy data from a large U.S. trial should lay concerns to rest, but worry the skirmishes
WINNIPEG, Manitoba (Reuters) – Indigenous communities in the Canadian province of Manitoba are shortening intervals between doses of COVID-19 vaccine after confirming several dozen infections after the initial jabs. Many provinces, eager to slow a
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. NEW YORK (AP) — The U.S government’s first look at the real-world use of COVID-19 vaccines found their effectiveness was nearly
With the hurry up-and-wait nature of the COVID-19 vaccine development, research and rollout, one demographic that has eagerly been awaiting more information on the efficacy of the shot is pregnant and breastfeeding people. Because pregnancy